Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...

Lexicon will move forward with no commercial sales team and no further promotional efforts for its Inpefa, a heart failure version of sotagliflozin approved by the FDA in 2023. The company will ...

However, an alternate approach leveraging both commercial and open-source software can mitigate risk, transform drug development, and accelerate time to market. To fully understand the potential ...

The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Aldeyra Therapeutics (NASDAQ:ALDX) announced FDA acceptance of its resubmitted market application for topical ocular ...

A clinical trial study will give vets medical and commercial-grade cannabis products to look at “real-world” use and its ...

Joseph J. Klaver and Ashleigh R. Mosley, both of Murray, were arrested on drug charges after Calloway County narcotics ...

Overdose deaths are dropping, but millions of former users live with compromised health and prospects.

Patrick Smith, President of Drug Development Solutions, Certara. Inflation and the Covid-19 pandemic have put pharmaceutical ...

Algorae Pharmaceuticals says its new AI-168 drug candidate shows early potential to improve on treatments to protect the ...